Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Anju Bhardwaj and Dr. Jim Januzzi
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Bailey Estes and Dr. Philippe Pibarot
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Daniel Addison, MD, and Danielle Shafer, DO, discuss the latest updates in the prevention and treatment of cardiovascular disease in patients with chronic lymphocytic leukemia.
Nicolas Palaskas, MD, and Susan Dent, MD, provide a review of the latest developments in the diagnosis and management of diverse immune checkpoint-related adverse cardiovascular events, including myocarditis.
Katelyn Atkins, MD, PhD discusses cardiovascular diseases associated with radiation therapy and risk mitigation approaches. Moderated by Sarah Waliany, MD, MS.
Commentary by Dr. Abdullah Al-Abcha and Dr. Dharam J. Kumbhani
Commentary by Dr. Megha Prasad and Dr. Akiko Maehara
Neeja Patel MD, and Unjali Gujral, MPH,PhD discuss the epidemiology of metabolic syndrome relating to cardiovascular disease, differences within various ethnic groups, the effect of acculturation, and approaches to address large population health in the future.
Audio Summary of the February Issue with Introduction by Dr. Bonnie Ky.